BAR Score Performance in Predicting Survival after Living Donor Liver Transplantation: A Single-Center Retrospective Study

Table 1

Demographic, clinical, laboratory, operative, and survival data.

n = 146	Mean ± SD, n (%)
Demographics
Age (years)	52.45 ± 8.54
Sex n (%)
Males	87 (59.6)
Females	59 (40.4)
Etiology of liver disease
HCV	125 (85.6)
HBV	6 (4.1)
Combined HCV and HBV	3 (2)
NAFLD	5 (3.4)
AIH	3 (2)
Others	4 (2.7)
Clinical data
BMI (kg/m^2)	25.47 ± 3.18
Preexisting DM	31 (21.2)
Preexisting HT	9 (6.2)
Life support	20 (13.7)
ICU stay	9.79 ± 3.40
Total hospital stay	24.79 ± 5.65
HCC	37 (25.3)
Laboratory data and scores
Albumin (gm/dL)	2.58 ± 0.78
Bilirubin (mg/dL)	3.67 ± 5.51
INR	1.40 ± 0.30
Creatinine (mg/dL)	0.98 ± 0.26
AST (IU/L)	66.37 ± 17.50
ALT (IU/L)	40.96 ± 10.79
Hb (gm/dL)	11.06 ± 1.13
WBC (×10³/mm³)	5.00 ± 1.45
Platelets (×10³/mm³)	172.87 ± 127.85
MELD score	14.45 ± 5.0
BAR score	7.58 ± 3.83
Donor age (years)	26.45 ± 6.06
Operative data
Graft weight (gm)	870.0 ± 15.0
GRWR	1.05 ± 0.15
CIT (minutes)	61.81 ± 25.49
WIT (minutes)	53.01 ± 16.20
TOT (hours)	13.88 ± 3.00
Blood transfusion (units)	5.17 ± 4.64
Survival data
Three-month survival	130 (89)
One-year survival	115 (78.8)
Five-year survival	105 (72)

BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Hb, hemoglobin; WBC, white blood count; HCV, hepatitis C virus; INR, international normalized ratio.